Illinois

Overview

Illinois became the first US state to legalize recreational sales by legislative act (rather than ballot initiative) when the Cannabis Regulation and Tax Act (CRTA, HB 1438) took effect on January 1, 2020. The state's medical program predates legalization by seven years: the Compassionate Use of Medical Cannabis Pilot Program Act launched in 2013 and was made permanent by CRTA in 2019.

The Illinois Department of Financial and Professional Regulation (IDFPR) licenses adult-use retailers, cultivators, and processors. The Illinois Department of Public Health (IDPH) administers the medical patient registry. The Illinois Department of Agriculture (IDOA) regulates cultivation centers.

Adult-use

• Public possession (residents): 30 g of cannabis flower.
• Public possession (non-residents): 15 g of cannabis flower.
• Concentrates: up to 5 g (both residents and non-residents).
• Home cultivation: medical patients only may cultivate up to 5 plants at home. Recreational users may not cultivate; unauthorized adult home growing carries a $200 civil penalty.
• Tax preference: medical-cannabis products are taxed at 1%, vs adult-use rates of 10–25% depending on potency.

Medical program

Qualifying conditions

The Compassionate Use Act enumerates 40+ qualifying conditions, including chronic pain, autism spectrum disorder, migraines, PTSD, IBD, MS, ALS, epilepsy, HIV/AIDS, cancer, glaucoma, fibromyalgia, lupus, and many neurological disorders. IDPH may add conditions administratively by rulemaking.

The Opioid Alternative Pilot Program allows opioid-prescribed patients to access medical cannabis as a substitute without going through full medical-card registration (a streamlined on-ramp that has substantially expanded the program's patient base).

Patient access

• Possession: 2.5 oz per 14-day supply unless the certifying practitioner approves an exception.
• Approved forms: flower, edibles, oils, tinctures, capsules, topicals, vapes.
• Home cultivation: up to 5 plants for registered patients (the only Illinois residents permitted to cultivate at home).
• Reciprocity: Illinois does not formally recognize out-of-state medical cards for the medical-program preferential tax rate, but out-of-state patients aged 21+ may purchase from any adult-use retailer.

Patients and caregivers

• Patient minimum age: no statutory floor. Minor patients require a designated caregiver (parent or legal guardian) plus practitioner certification.
• Caregiver minimum age: 21.
• Caregivers per patient: 1 designated caregiver per patient.
• Caregiver requirements: Illinois resident; criminal background check; cannot consume the patient's cannabis.

Patient registration steps

1. Schedule a visit with an Illinois-licensed physician, APRN, or PA willing to certify a qualifying condition. The certifying practitioner must establish a bona fide patient-provider relationship.
2. The provider submits a written certification to the IDPH Medical Cannabis Patient Program portal.
3. The patient completes the application through the IDPH portal, submits identity documents, proof of Illinois residency, and a current photo. The standard application fee is $50 (one year), $100 (two years), or $125 (three years). Reduced fees apply for veterans and patients receiving SSI or SSDI.
4. Approved patients receive a state-issued ID card valid for the chosen registration term. The card authorizes purchases at any licensed Illinois dispensary under medical-program pricing, the 1% tax rate, and the home-cultivation right.

Opioid Alternative Pilot Program (OAPP)

Patients with opioid prescriptions may use the streamlined OAPP pathway, which:

• Requires a written certification from a practitioner that the patient could benefit from medical cannabis as an alternative to opioids.
• Issues a temporary registry status valid for 90 days (renewable).
• Does not require the patient to identify a specific Compassionate Use Act qualifying condition.

The OAPP framework has substantially expanded the program's patient base, particularly for chronic-pain patients who would otherwise face the full Compassionate Use Act registration process.

Minor patients require a designated caregiver and a second physician's concurring certification. The caregiver completes a separate application and Illinois State Police background check.

Reciprocity and visiting patients

Illinois's framework is dual-track for visitors:

• Adult-use: any visitor 21 or older with a government-issued photo ID may purchase from a licensed adult-use retailer under the 15 g non-resident flower cap and 5 g concentrate cap.
• Medical: Illinois does not formally recognize out-of-state medical cards for the medical-program 1% tax rate. Visiting medical patients access cannabis through the adult-use retail framework.

The medical-program tax preference is significant for high-volume patients (1% vs up to 25% for adult-use). Visiting medical patients cannot access this preference or the higher 2.5 oz / 14-day medical possession cap.

Employment and workplace

Illinois provides notable employment protections for adult-use cannabis under CRTA, with carve-outs:

• Off-duty use: the Illinois Right to Privacy in the Workplace Act, as amended by CRTA, prohibits employers from refusing to hire or discharging an employee for use of lawful products off the employer's premises during non-working hours.
• Workplace impairment: employers retain authority to discipline employees for on-the-job impairment as reasonably documented.
• Safety-sensitive positions: Illinois carve-outs are narrower than in many states.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level protection.
• Workers' compensation: post-incident testing positive for THC may affect benefits if impairment at the time of incident is established.

The Illinois employment-protection framework has been tested in litigation since 2020, with mixed outcomes. Public-employee positions, healthcare licensing, and CDL holders face additional licensing-board exposure beyond employer discipline.

Hemp-derived intoxicants

Illinois enacted comprehensive restrictions on hemp-derived intoxicating cannabinoids through legislation in 2024 and follow-on rulemaking, placing delta-8 THC, delta-9 THC, delta-10 THC, THC-O, and HHC products under the IDFPR's regulatory authority. Outside the licensed adult-use and medical-cannabis supply chain, these products are not lawful for retail sale to consumers.

Social equity and expungement

CRTA established one of the more substantive social-equity frameworks in the country. Provisions include:

• License-application preferences for social-equity applicants from disproportionately impacted areas.
• A R3 (Restore, Reinvest, Renew) grant program funded by cannabis tax revenue.
• Automatic expungement of low-level cannabis convictions: the Illinois State Police completed roughly 500,000 record expungements since 2019.
• Cannabis Business Development Fund and cannabis-equity loan programs.

Implementation has faced licensing-delay litigation but the framework remains the model that many subsequent state adult-use frameworks have adapted.

Recent legislative and regulatory history

Notable developments:

• 2013: Compassionate Use of Medical Cannabis Pilot Program Act enacted.
• 2018: Opioid Alternative Pilot Program added.
• 2019: CRTA signed; effective January 1, 2020.
• 2020: licensed adult-use retail sales began January 1.
• 2021-2023: social-equity license disputes, lottery-allocation litigation, license caps and craft-cultivator rollout.
• 2024: hemp-derived intoxicant restrictions enacted; on-premises consumption pilots licensed in some municipalities.
• 2025-2026: continued legislative work on advertising, social-equity license expansion, and dispensary licensing balance.

The April 2026 federal Schedule III rescheduling order produced no immediate Illinois legislative response.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Naval Station Great Lakes, Scott Air Force Base, Rock Island Arsenal), and interstate highways. Shawnee National Forest, Lincoln Home National Historic Site, and several National Wildlife Refuges fall under federal jurisdiction where cannabis prohibition applies. O'Hare International, Midway International, and other airports apply TSA cannabis-contraband rules. I-55, I-57, I-64, I-70, I-72, I-74, I-80, I-88, I-90, and I-94 corridors see active state-patrol and federal drug-interdiction activity, particularly at the Wisconsin, Iowa, Missouri, Kentucky, and Indiana borders.